IMVT
#1015
Immunovant, Inc. - Common Stock
41.2 0 USD
-0.06%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.98%
Monthly Change
+6.71%
6 month change
+50.53%
Year Change
+114.47%
Previous Close
43.8 2
Open
41.2 0
Low
41.2 0
High
41.2 0
Volume
155
Financials
- Market Capitalization 8.51 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.97
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 992 |  PCVX Vaxcyte, Inc. - Common Stock | 59.84 USD | -2.16% | -3.95% | +13.01% | +41.47% | 8.90 B USD | ||
| 1013 |  IBRX ImmunityBio, Inc. - Common Stock | 8.05 USD | -4.17% | +4.82% | +11.50% | +244.02% | 8.53 B USD | ||
| 1024 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1040 |  TGTX TG Therapeutics, Inc. - Common Stock | 53.93 USD | -3.21% | +1.39% | +0.88% | +83.62% | 8.26 B USD |
Frequently asked questions about Immunovant, Inc. Common Stock
What is the Immunovant, Inc. Common Stock stock price today?
The current price of Immunovant, Inc. Common Stock (IMVT) is 41.20. Over the past 24 hours, the stock has changed by -5.98%. Follow the IMVT chart for real-time price dynamics.
What is the stock ticker of Immunovant, Inc. Common Stock?
Immunovant, Inc. Common Stock trades under the ticker IMVT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunovant, Inc. Common Stock stock going up?
IMVT has changed by -6.36% over the last week, +6.71% over the last month, and +114.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immunovant, Inc. Common Stock?
Immunovant, Inc. Common Stock currently has a market capitalization of 8.51 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immunovant, Inc. Common Stock earnings last quarter?
Last quarter, Immunovant, Inc. Common Stock reported earnings of -0.75 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immunovant, Inc. Common Stock net income for the last quarter?
Immunovant, Inc. Common Stock reported net income of -153.22 M for the last quarter. The previous quarter showed -147.86 M, which means net income changed by -3.63%.
How many employees does Immunovant, Inc. Common Stock have?
As of the latest available data, Immunovant, Inc. Common Stock has 315 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immunovant, Inc. Common Stock stock?
You can buy Immunovant, Inc. Common Stock (IMVT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunovant, Inc. Common Stock stock?
Investing in Immunovant, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMVT chart and related analysis on metatrader.com as part of your research.